Cargando…
Efficacy of the exhalation delivery system with fluticasone in patients with chronic rhinosinusitis with nasal polyps whose symptoms recur after sinus surgery
BACKGROUND: Sinus surgery removes inflamed tissue, restores airflow, and improves delivery of medication into surgically opened spaces. The exhalation delivery system with fluticasone (EDS‐FLU; XHANCE(®)) uses a novel delivery system to create closed‐palate, positive‐pressure, bidirectional mechanic...
Autores principales: | Ow, Randall A., Soler, Zachary M., Sindwani, Raj, Leopold, Donald A., Lee, Jivianne T., Mahmoud, Ramy A., Han, Joseph K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084243/ https://www.ncbi.nlm.nih.gov/pubmed/35674488 http://dx.doi.org/10.1002/alr.23043 |
Ejemplares similares
-
NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the
Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With
Nasal Polyps
por: Sindwani, Raj, et al.
Publicado: (2018) -
Characterization of Cytokines and Proliferation Marker Ki-67 in Chronic Rhinosinusitis with Recurring Nasal Polyps
por: Viksne, Rudolfs Janis, et al.
Publicado: (2022) -
EXHANCE‐12: 1‐year study of the exhalation delivery system with fluticasone (EDS‐FLU) in chronic rhinosinusitis
por: Palmer, James N., et al.
Publicado: (2018) -
LB1581. Exhalation Delivery System with Fluticasone (EDS-FLU) Significantly Reduces Acute Exacerbations and Associated Antibiotic Use in Chronic Rhinosinusitis
por: Mahmoud, Ramy
Publicado: (2022) -
Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials
por: Bachert, Claus, et al.
Publicado: (2022)